Filter

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 11 items for :

  • hospice care x
  • Refine by access: All content x
Clear All
Jaydira Del Rivero Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA

Search for other papers by Jaydira Del Rivero in
Google Scholar
PubMed Close
,
Josh Mailman NorCal CarciNET Community, Oakland, California, USA

Search for other papers by Josh Mailman in
Google Scholar
PubMed Close
,
Michael W Rabow Department of Internal Medicine, Division of Palliative Medicine, University of California, San Francisco, San Francisco, California, USA

Search for other papers by Michael W Rabow in
Google Scholar
PubMed Close
,
Jennifer A Chan Harvard Medical School, Program in Carcinoid and Neuroendocrine Tumors, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Jennifer A Chan in
Google Scholar
PubMed Close
,
Sarah Creed Good Shepherd Community Care, Harvard Kennedy School, Natick, Massachusetts, USA

Search for other papers by Sarah Creed in
Google Scholar
PubMed Close
,
Hagen F Kennecke Providence Cancer Institute Franz Clinic, Portland Providence Medical Center, Portland, Oregon, USA

Search for other papers by Hagen F Kennecke in
Google Scholar
PubMed Close
,
Janice Pasieka Department of Surgery, Section of General Surgery, University of Calgary, Cumming School of Medicine, Calgary, Canada

Search for other papers by Janice Pasieka in
Google Scholar
PubMed Close
,
Jennifer Zuar Department of Internal Medicine, Division of Geriatrics and Palliative Medicine, Alpert Medical School, Providence, Rhode Island, USA

Search for other papers by Jennifer Zuar in
Google Scholar
PubMed Close
,
Simron Singh Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Search for other papers by Simron Singh in
Google Scholar
PubMed Close
, and
Lauren Fishbein Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA

Search for other papers by Lauren Fishbein in
Google Scholar
PubMed Close

larger approach to care and should be offered to those at any point in their cancer journey. Hospice differs from palliative care since it provides care specifically at the end of life and in a place which a patient calls home, be it a private residence

Article Type:
Other
DOI:
https://doi.org/10.1530/ERC-22-0226
Volume/Issue:
Volume 30: Issue 7
Open access
Markus Luster
Search for other papers by Markus Luster in
Google Scholar
PubMed Close
,
Francesco Lippi
Search for other papers by Francesco Lippi in
Google Scholar
PubMed Close
,
Barbara Jarzab
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed Close
,
Petros Perros
Search for other papers by Petros Perros in
Google Scholar
PubMed Close
,
Michael Lassmann
Search for other papers by Michael Lassmann in
Google Scholar
PubMed Close
,
Christoph Reiners
Search for other papers by Christoph Reiners in
Google Scholar
PubMed Close
, and
Furio Pacini
Search for other papers by Furio Pacini in
Google Scholar
PubMed Close

second patient with a partial response including good quality of life died at about 3 years of follow-up. A further patient was discharged from hospital into hospice care. When published results of rhTSH-aided treatment are being evaluated, data

Article Type:
Review Article
DOI:
https://doi.org/10.1677/erc.1.00830
Volume/Issue:
Volume 12: Issue 1
Free access
Nicola Fazio Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Nicola Fazio in
Google Scholar
PubMed Close
,
Lorenzo Gervaso Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Molecular Medicine Program, University of Pavia, Pavia, Italy

Search for other papers by Lorenzo Gervaso in
Google Scholar
PubMed Close
,
Thorvardur R Halfdanarson Division of Medical Oncology Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed Close
,
Mohamad Sonbol Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA

Search for other papers by Mohamad Sonbol in
Google Scholar
PubMed Close
,
Rachel A Eiring Division of Medical Oncology Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Rachel A Eiring in
Google Scholar
PubMed Close
,
Sara Pusceddu Division of Medical Oncology, National Cancer Institute, Milan, Italy

Search for other papers by Sara Pusceddu in
Google Scholar
PubMed Close
,
Natalie Prinzi Division of Medical Oncology, National Cancer Institute, Milan, Italy

Search for other papers by Natalie Prinzi in
Google Scholar
PubMed Close
,
Benedetta Lombardi Stocchetti Division of Medical Oncology, National Cancer Institute, Milan, Italy

Search for other papers by Benedetta Lombardi Stocchetti in
Google Scholar
PubMed Close
,
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed Close
,
David J Gross Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel

Search for other papers by David J Gross in
Google Scholar
PubMed Close
,
Thomas Walter Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France

Search for other papers by Thomas Walter in
Google Scholar
PubMed Close
,
Patrick Robelin Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France

Search for other papers by Patrick Robelin in
Google Scholar
PubMed Close
,
Catherine Lombard-Bohas Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France

Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed Close
,
Samuele Frassoni Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy

Search for other papers by Samuele Frassoni in
Google Scholar
PubMed Close
,
Vincenzo Bagnardi Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy

Search for other papers by Vincenzo Bagnardi in
Google Scholar
PubMed Close
,
Lorenzo Antonuzzo Clinical Oncology Unit, Careggi University Hospital, Florence, Italy
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

Search for other papers by Lorenzo Antonuzzo in
Google Scholar
PubMed Close
,
Clotilde Sparano Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences ’Mario Serio’, University of Florence, Florence, Italy

Search for other papers by Clotilde Sparano in
Google Scholar
PubMed Close
,
Sara Massironi Division of Gastroenterology, and Center for Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, University of Milano-Bicocca School of Medicine, Monza, Italy

Search for other papers by Sara Massironi in
Google Scholar
PubMed Close
,
Fabio Gelsomino Division of Oncology. Department of Hematology and Oncology, University Hospital of Modena, Modena, Italy

Search for other papers by Fabio Gelsomino in
Google Scholar
PubMed Close
,
Alberto Bongiovanni Oncologia medica, IRCCS Istituto Romagnolo per lo Studio dei Tumori ’Dino Amadori’, IRST S.r.l., Meldola, Italy

Search for other papers by Alberto Bongiovanni in
Google Scholar
PubMed Close
,
Nicoletta Ranallo Oncologia medica, IRCCS Istituto Romagnolo per lo Studio dei Tumori ’Dino Amadori’, IRST S.r.l., Meldola, Italy

Search for other papers by Nicoletta Ranallo in
Google Scholar
PubMed Close
,
Salvatore Tafuto Oncologia Sarcomi e Tumori rari, I.R.C.C.S. Ist. Naz. Tumori di Napoli ’G. Pascale’, Napoli, Italy

Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed Close
,
Maura Rossi Oncology Unit and Centro Documentazione Osteonecrosi, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Search for other papers by Maura Rossi in
Google Scholar
PubMed Close
,
Mauro Cives Department of Interdisciplinary Medicine, University of Bari ’Aldo Moro’, Bari, Italy

Search for other papers by Mauro Cives in
Google Scholar
PubMed Close
,
Ibrahim Rasul Kakil National Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

Search for other papers by Ibrahim Rasul Kakil in
Google Scholar
PubMed Close
,
Hytam Hamid Department of Surgery, Al-Moalem Medical City, Khartoum, Sudan

Search for other papers by Hytam Hamid in
Google Scholar
PubMed Close
,
Alessandra Chirco UO Oncologia Medica ASST Papa Giovanni XXIII, Bergamo, Italy

Search for other papers by Alessandra Chirco in
Google Scholar
PubMed Close
,
Michela Squadroni Oncologia medica, Humanitas Gavazzeni Bergamo, Bergamo, Italy

Search for other papers by Michela Squadroni in
Google Scholar
PubMed Close
,
Anna La Salvia Medical Oncology Department, Hospital Universitario Doce de Octubre, Imas12, UCM, Madrid, Spain

Search for other papers by Anna La Salvia in
Google Scholar
PubMed Close
,
Jorge Hernando Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for other papers by Jorge Hernando in
Google Scholar
PubMed Close
,
Johannes Hofland Department of Internal Medicine, Sector Endocrinology, Rotterdam, the Netherlands

Search for other papers by Johannes Hofland in
Google Scholar
PubMed Close
,
Anna Koumarianou Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Anna Koumarianou in
Google Scholar
PubMed Close
,
Sabrina Boselli Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Sabrina Boselli in
Google Scholar
PubMed Close
,
Darina Tamayo Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Darina Tamayo in
Google Scholar
PubMed Close
,
Cristina Mazzon Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Cristina Mazzon in
Google Scholar
PubMed Close
,
Manila Rubino Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Manila Rubino in
Google Scholar
PubMed Close
, and
Francesca Spada Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy

Search for other papers by Francesca Spada in
Google Scholar
PubMed Close

regression models were used to assess the association between selected variables with hospitalization for COVID-19 management, pneumonia as clinical course of the infection, sub-intensive or intensive care as COVID-19 treatment, and death due to COVID-19

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0395
Volume/Issue:
Volume 30: Issue 6
Restricted access
Jack Junjie Chan Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore

Search for other papers by Jack Junjie Chan in
Google Scholar
PubMed Close
,
Yirong Sim Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore

Search for other papers by Yirong Sim in
Google Scholar
PubMed Close
,
Samuel Guan Wei Ow Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Search for other papers by Samuel Guan Wei Ow in
Google Scholar
PubMed Close
,
Joline Si Jing Lim Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Search for other papers by Joline Si Jing Lim in
Google Scholar
PubMed Close
,
Grace Kusumawidjaja Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Grace Kusumawidjaja in
Google Scholar
PubMed Close
,
Qingyuan Zhuang Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Qingyuan Zhuang in
Google Scholar
PubMed Close
,
Ru Xin Wong Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Ru Xin Wong in
Google Scholar
PubMed Close
,
Fuh Yong Wong Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Fuh Yong Wong in
Google Scholar
PubMed Close
,
Veronique Kiak Mien Tan Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore

Search for other papers by Veronique Kiak Mien Tan in
Google Scholar
PubMed Close
, and
Tira Jing Ying Tan Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore

Search for other papers by Tira Jing Ying Tan in
Google Scholar
PubMed Close

. Cancer care services During the ‘circuit breaker’ period in Singapore, hospital-based cancer care services, inpatient hospices and home palliative care are considered as essential and remain operational. Otherwise, cancer screening and surveillance

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0157
Volume/Issue:
Volume 27: Issue 9
Free access
Igryl S Cordero-Hernandez Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Igryl S Cordero-Hernandez in
Google Scholar
PubMed Close
,
Alicia C Ross Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Alicia C Ross in
Google Scholar
PubMed Close
,
Arvind Dasari Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Arvind Dasari in
Google Scholar
PubMed Close
,
Daniel M Halperin Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Daniel M Halperin in
Google Scholar
PubMed Close
,
Beth Chasen Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Beth Chasen in
Google Scholar
PubMed Close
, and
James C Yao Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by James C Yao in
Google Scholar
PubMed Close

transitioned to hospice care soon after treatment initiation. All patients with transformation died from progressive disease with median overall survival (OS) after transformation of 3.3 months (95% CI 2.1–4.4) ( Fig. 2 ). Median OS from start of PRRT for

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0203
Volume/Issue:
Volume 31: Issue 4
Restricted access
Theodora S Ross Department of Internal Medicine and High-Risk Cancer Program, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas 75390-8852, USA

Search for other papers by Theodora S Ross in
Google Scholar
PubMed Close

primary medical team has real-time responsibility for care, even if the patients become research subjects of other doctors. In the dawn of the genomic age, when genetic signatures are predicted, by some, to become road maps to sickness and health, the need

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0186
Volume/Issue:
Volume 19: Issue 4
Free access
S L Asa Department of Pathology and Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Search for other papers by S L Asa in
Google Scholar
PubMed Close
,
O Casar-Borota Department of Pathology, Uppsala University Hospital, Uppsala, Sweden

Search for other papers by O Casar-Borota in
Google Scholar
PubMed Close
,
P Chanson Service of Endocrinology and Reproductive Diseases, Bicêtre Hospital, Paris, France

Search for other papers by P Chanson in
Google Scholar
PubMed Close
,
E Delgrange Department of Medicine, University of Louvain, Mont-sur-Meuse, Belgium

Search for other papers by E Delgrange in
Google Scholar
PubMed Close
,
P Earls Department of Anatomical Pathology, St Vincent’s Hospital, Sydney, Australia

Search for other papers by P Earls in
Google Scholar
PubMed Close
,
S Ezzat Department of Medicine and Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada

Search for other papers by S Ezzat in
Google Scholar
PubMed Close
,
A Grossman Department of Endocrinology, University of Oxford, Oxford, UK

Search for other papers by A Grossman in
Google Scholar
PubMed Close
,
H Ikeda Research Institute for Pituitary Disease, Southern Tohoku General Hospital, Fukushima, Japan

Search for other papers by H Ikeda in
Google Scholar
PubMed Close
,
N Inoshita Department of Pathology, Toranomon Hospital, Tokyo, Japan

Search for other papers by N Inoshita in
Google Scholar
PubMed Close
,
N Karavitaki Department of Endocrinology, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK

Search for other papers by N Karavitaki in
Google Scholar
PubMed Close
,
M Korbonits Division of Endocrinology, Queen Mary Hospital, Barts and the London School of Medicine, London, UK

Search for other papers by M Korbonits in
Google Scholar
PubMed Close
,
E R Laws Jr Department of Neurosurgery, Harvard Medical School, Brigham & Women’s Hospital, Boston, Massachusetts, USA

Search for other papers by E R Laws Jr in
Google Scholar
PubMed Close
,
M B Lopes Departments of Pathology and Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA

Search for other papers by M B Lopes in
Google Scholar
PubMed Close
,
N Maartens Department of Neurosurgery, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia

Search for other papers by N Maartens in
Google Scholar
PubMed Close
,
I E McCutcheon Department of Neurosurgery, UT MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by I E McCutcheon in
Google Scholar
PubMed Close
,
O Mete Department of Pathology and Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Search for other papers by O Mete in
Google Scholar
PubMed Close
,
H Nishioka Department of Neurosurgery, Toranomon Hospital, Tokyo, Japan

Search for other papers by H Nishioka in
Google Scholar
PubMed Close
,
G Raverot Department of Endocrinology, Groupement Hospitalier EST, Hospices Civils de Lyon, University of Lyon, Lyon, France

Search for other papers by G Raverot in
Google Scholar
PubMed Close
,
F Roncaroli Department of Neuropathology, Imperial College, London, UK

Search for other papers by F Roncaroli in
Google Scholar
PubMed Close
,
W Saeger Institute of Neuropathology of the University of Hamburg, Hamburg, Germany

Search for other papers by W Saeger in
Google Scholar
PubMed Close
,
L V Syro Department of Neurosurgery, Hospital Pablo Tobon Uribe, Medellin, Colombia

Search for other papers by L V Syro in
Google Scholar
PubMed Close
,
A Vasiljevic Department of Pathology, Groupement Hospitalier EST, Hospices Civils de Lyon, University of Lyon, Lyon, France

Search for other papers by A Vasiljevic in
Google Scholar
PubMed Close
,
C Villa Department of Pathology, Hôpital Foch, Suresnes, France

Search for other papers by C Villa in
Google Scholar
PubMed Close
,
A Wierinckx INSERM U1052, Cancer Research Center of Lyon, University of Lyon, Lyon, France

Search for other papers by A Wierinckx in
Google Scholar
PubMed Close
,
J Trouillas Faculty of Medicine Lyon-Est, University of Lyon, Lyon, France

Search for other papers by J Trouillas in
Google Scholar
PubMed Close
, and
and the attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016
Search for other papers by and the attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016 in
Google Scholar
PubMed Close

. Patients and health care providers have long expressed frustration that these lesions are considered rare, benign and inconsequential. In most jurisdictions, they are not reported in cancer registries. Pituitary patients are often denied access to and

Article Type:
Article Commentary
DOI:
https://doi.org/10.1530/ERC-17-0004
Volume/Issue:
Volume 24: Issue 4
Free access
Marcia S Brose Department of Otorhinolaryngology: Head and Neck Surgery, Abramson Cancer Center of the University of Pennsylvania, Stellar-Chance Laboratories Mezzanine, Philadelphia, Pennsylvania, USA

Search for other papers by Marcia S Brose in
Google Scholar
PubMed Close
,
Johannes Smit Department of Internal Medicine, Radboud University Nijmegen Medical Center, 463 General Internal Medicine, Nijmegen, Netherlands

Search for other papers by Johannes Smit in
Google Scholar
PubMed Close
,
Chia-Chi Lin Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan

Search for other papers by Chia-Chi Lin in
Google Scholar
PubMed Close
,
Fabian Pitoia Division of Endocrinology, Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina

Search for other papers by Fabian Pitoia in
Google Scholar
PubMed Close
,
Marc Fellous Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA

Search for other papers by Marc Fellous in
Google Scholar
PubMed Close
,
Yoriko DeSanctis Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA

Search for other papers by Yoriko DeSanctis in
Google Scholar
PubMed Close
,
Martin Schlumberger Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy and Université Paris Saclay, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
,
Masayuki Tori Department of Endocrine Surgery, Osaka Police Hospital, Tennoujiku, Osaka, Japan

Search for other papers by Masayuki Tori in
Google Scholar
PubMed Close
, and
Iwao Sugitani Department of Endocrine Surgery, Nippon Medical School Graduate School of Medicine, Bunkyo-Ku, Tokyo, Japan

Search for other papers by Iwao Sugitani in
Google Scholar
PubMed Close

treated with MKIs for advanced disease or if they are in hospice (end-of-life) care. Treatments The decision to treat with sorafenib or other MKIs (for e.g., lenvatinib) will be based on the investigator’s clinical judgment at study entry

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-17-0016
Volume/Issue:
Volume 24: Issue 5
Open access
Jennifer W Carlisle Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Jennifer W Carlisle in
Google Scholar
PubMed Close
,
Caroline S Jansen Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA
Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Caroline S Jansen in
Google Scholar
PubMed Close
,
Mehmet Asim Bilen Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Mehmet Asim Bilen in
Google Scholar
PubMed Close
, and
Haydn Kissick Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA

Search for other papers by Haydn Kissick in
Google Scholar
PubMed Close

transitioning care to palliation and/or hospice. In effort to limit further spread, some hospital systems are making the tough decision to restrict or deny any visitors, which can be heartbreaking for patients at the end of life, whether due to SARS-COV-2 or

Article Type:
Article Commentary
DOI:
https://doi.org/10.1530/ERC-20-0187
Volume/Issue:
Volume 27: Issue 9
Free access
Derek Raghavan Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Derek Raghavan in
Google Scholar
PubMed Close
,
Antoinette R Tan Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Antoinette R Tan in
Google Scholar
PubMed Close
,
E Shannon Story Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by E Shannon Story in
Google Scholar
PubMed Close
,
Earle F Burgess Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Earle F Burgess in
Google Scholar
PubMed Close
,
Laura Musselwhite Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Laura Musselwhite in
Google Scholar
PubMed Close
,
Edward S Kim Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Edward S Kim in
Google Scholar
PubMed Close
, and
Peter E Clark Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Peter E Clark in
Google Scholar
PubMed Close

of medical management issues for around 5–15% of patients, the impact and prevalence of asymptomatic carriers, and the global inexperience in pandemic care ( Zhu et al. 2020 ). The initial cases were reported in Wuhan, China, in December 2019, and

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0229
Volume/Issue:
Volume 27: Issue 9
Free access